Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

NGB 2904, Tocris Bioscience™

Catalog No. p-4784192 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Potent and selective D3 antagonist

NGB 2904 is a potent and selective dopamine D3 receptor antagonist (Ki values are 1.4, 217, 223, 642, > 5000, > 10000 and > 10000 nM for D3, D2, 5-HT2, α1, D4, D1 and D5 receptors respectively). Potently antagonizes quinpirole -stimulated mitogenesis (IC50 = 6.8 nM). Attenuates cocaine's rewarding effects and inhibits relapse to drug-seeking behavior.

Chemical Identifiers

CAS 189061-11-8
Molecular Formula C28H30Cl3N3O
Molecular Weight (g/mol) 530.918
InChI Key PFIWYJNBKGCVFM-UHFFFAOYSA-N
Synonym ngb 2904 hydrochloride, n-4-4-2,3-dichlorophenyl-1-piperazinyl butyl-9h-fluorene-2-carboxamide, n-4-4-2,3-dichlorophenyl-1-piperazinyl butyl-9h-fluorene-2-carboxamide hydrochloride, 28h29cl2n3o.hcl, ngb 2904 hydrochloride hplc, n-4-4-2,3-dichlorophenyl piperazin-1-yl butyl-9h-fluorene-2-carboxamide hcl, n-4-4-2,3-dichlorophenyl piperazin-1-yl butyl-9h-fluorene-2-carboxamide hydrochloride
PubChem CID 19366304
IUPAC Name N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]-9H-fluorene-2-carboxamide;hydrochloride
SMILES C1CN(CCN1CCCCNC(=O)C2=CC3=C(C=C2)C4=CC=CC=C4C3)C5=C(C(=CC=C5)Cl)Cl.Cl

Specifications

Quantity 10 mg
Formula Weight 530.92
Percent Purity >98%
Chemical Name or Material NGB 2904
Recommended Storage Desiccate at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.